分组1 - Tetratherix announced plans to develop a nasal spray GLP-1 drug similar to Ozempic, utilizing its "polymer platform" for drug delivery, although analysts suggest the GLP-1 hype may be waning [2] - Core Lithium secured a $170 million investment, partly from Glencore, to restart its Finniss project, raising questions about the potential return of lithium market enthusiasm to previous highs [3] - ARN Media canceled its contract with Kyle Sandilands, who is now considering legal action or potentially acquiring a controlling stake in the company, highlighting the volatility in the media sector [4] 分组2 - NOVONIX received a notice from NASDAQ, giving the company 180 days to improve its share price, which has been below $1 for ten consecutive days, indicating investor uncertainty [5] - West Wits Mining poured its first bar of gold, but the market reaction was muted due to gold prices being under $5,000, reflecting a challenging environment for gold producers [6] - AML3D experienced a rise in stock price following a contract with the US Department of War, benefiting from increased interest in defense-related stocks amid geopolitical tensions [6]